PAD After Lower Extremity Revascularization
PAD After Lower Extremity Revascularization is organized by Paradigm Medical Communications, LLC.
Release Date: April 28, 2023
Expiration Date: April 28, 2024
Program Overview:
Data suggest that many patients with PAD are not receiving evidence-based therapy, leaving them at high risk of major adverse limb events and major adverse cardiovascular events. Which treatment regimens are both effective and safe? Join our expert faculty for a case-based discussion of the new PAD treatment paradigm, which has shifted recently based on a robust body of evidence.
Learning Objectives:
Upon completion of this activity, participants should be able to:
• Outline key clinical trial data related to the use of dual pathway inhibition (DPI) in the treatment of CAD and/or PAD
• Develop CAD and/or PAD treatment plans that demonstrate appropriate use of DPI in heterogeneous patients